Case Report| Volume 36, ISSUE 1, P242-245, January 2022

Factor V Deficiency (Owren's Disease) in a Patient at High Risk for Transfusion-Associated Circulatory Overload and Bleeding During Laser Lead Extraction

Published:February 12, 2021DOI:
      Congenital factor V deficiency is an extremely rare abnormality and may be associated with significant bleeding as a result of trauma or surgery. Perioperative management primarily includes the administration of fresh frozen plasma to replace the deficient clotting factor. Acute administration of multiple blood products is a risk factor for transfusion-associated circulatory overload. Herein, the case of a 71-year-old man with an ejection fraction of 13% and a history of congenital factor V deficiency who was at risk for significant bleeding and transfusion-associated circulatory overload who underwent successful complex extraction of a right atrial pacing lead is reported.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Peyvandi F
        • Menegatti M.
        Treatment of rare factor deficiencies in 2016.
        Hematology Am Soc Hematol Educ Program. 2016; 2016: 663-669
        • Tabibian S
        • Shiravand Y
        • Shams M
        • et al.
        A comprehensive overview of coagulation factor V and congenital factor V deficiency.
        Semin Thromb Hemost. 2019; 45: 523-543
        • Huang JN
        • Koerper MA.
        Factor V deficiency: A concise review.
        Haemophilia. 2008; 14: 1164-1168
        • Thakar K
        • Parikh K
        • Chen Y
        • et al.
        Isolated factor V deficiency in a patient with elevated PT and aPTT during routine pre-operative laboratory screening.
        Stem Cell Invest. 2014; 8: 1-4
        • Neschis DG
        • Heyman MR
        • Cheanvechai V
        • et al.
        Coagulopathy as a result of factor V inhibitor after exposure to bovine topical thrombin.
        J Vasc Surg. 2002; 35: 400-402
        • Owren PA
        Parahaemophilia: Haemorrhagic diasthesis due to absence of a previously unknown clotting factor.
        Lancet. 1947; 1: 446-448
        • Friedman IA
        • Quick AJ
        • Higgins F
        • et al.
        Hereditary labile factor (factor V) deficiency.
        JAMA. 1961; 175: 370-374
        • Brink AJ
        • Kingsley CS.
        Familial disorder of blood coagulation due to deficiency of labile factor.
        Quart J Med. 1952; 21: 19-31
        • Yousef S
        • Bin Mahmood SU
        • Mori M
        • et al.
        On-pump CABG in a patient with severe factor V deficiency.
        Haemophilia. 2019; 25: e324-e326
        • Brown L
        • Tilzer L
        • Plapp F.
        Factor V and VIII deficiency treated with therapeutic plasma exchange prior to redo mitral valve replacement.
        J Clin Apher. 2017; 32: 196-199
        • Mapp SI
        • Paters P
        • Solano C.
        Successful mitral valve repair in a patient with factor V deficiency.
        Haemophilia. 2011; 17: 170-171
        • Yotsumoto G
        • Masuda H
        • Toyokawa
        • et al.
        Off-pump coronary artery bypass grafting in a patient with congenital factor V deficiency: Report of a case.
        Surg Today. 2005; 35: 142-144
        • Howard C
        • Lipe B.
        Combined deficiency of factor V and factor VIII: Management during cardiopulmonary surgery.
        Blood Coagul Fibinolysis. 2017; 28: 267-268
        • Sood N
        • Martin DT
        • Lampet R
        • et al.
        Incidence and predictors of perioperative complications with transvenous led extractions.
        Circ Arrhythm Electrophysiol. 2018; 11e004768
        • Brunner MP
        • Yu C
        • Hussein AA
        • et al.
        Normogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction.
        Heart Rhythm. 2015; 12: 2381-2386
        • Clifford L
        • Jia Q
        • Subramanian A
        • et al.
        Risk factors and clinical outcomes associated with transfusion-associated circulatory overload.
        Anesthesiology. 2017; 126: 409-418

      Linked Article